PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - van der Heijde, Desiree
TI  - The ATLAS Trial: Long-Term Adalimumab Treatment Reduces Signs and Symptoms in Ankylosing Spondylitis Patients
DP  - 2006 Oct 01
TA  - MD Conference Express
PG  - 15--16
VI  - 6
IP  - 3
4099  - http://mdc.sagepub.com/content/6/3/15.2.short
4100  - http://mdc.sagepub.com/content/6/3/15.2.full
AB  - The Adalimumab Trial Evaluating Long-Term Efficacy and Safety in Ankylosing Spondylitis (AS) or ATLAS trial was a double-blind, phase III, placebo-controlled study to evaluate the ability of adalimumab to reduce signs and symptoms of AS over a one-year period.